Medmira Inc. Stock
€0.040
Your prediction
Pros and Cons of Medmira Inc. in the next few years
Pros
Cons
Performance of Medmira Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Medmira Inc. | 0.000% | 0.000% | -5.882% | -15.789% | -50.000% | -54.545% | - |
Theralase Technologies Inc | 3.670% | 3.670% | 8.654% | 11.881% | -29.375% | -44.608% | -13.740% |
Atossa Genetics Inc | -1.600% | -9.273% | 3.134% | -42.173% | -25.052% | -27.658% | -80.579% |
Aortech International plc | 0.540% | 0.538% | -15.766% | 2.747% | -16.518% | -77.195% | -91.422% |
News

MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 7, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate

MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
Halifax, Nova Scotia, 17th of April, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) and Lovell® Government Services announced today that they have partnered to serve federal healthcare systems

MedMira Announces Partnership with MediGroup Physician Services in the United States
Halifax, Nova Scotia, 27th of February, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today its partnership with MediGroup, a leader in the US health care industry since 1999. This new